{"paper_id":"2a024e45-8e91-4e2f-8f11-7a29c34809df","body_text":"Abstract\nTo study the steroid hormone-induced growth mechanisms of endometriosis, the immunohistochemical expression of steroid hormone receptor cofactors was investigated in 37 cases of endometriotic epithelia and was compared with that of eutopic endometria of identical patients. The expression of steroid receptor coactivators (p300/CBP and SRC-1) and corepressors (NCoR and SMRT) was examined in relation to the estrogen receptor (ER), the progesterone receptor (PR), and Ki-67. Results of immunostaining were indicated as a “positivity index” (PI, full score; 100). The expression of ER and PR in endometriotic epithelia largely resembled that in eutopic endometria, however, the expression of Ki-67 in the proliferative phase (PI 13.8 ± 2.4, mean ± SD) was significantly lower than that in eutopic endometria (32.6 ± 10.6). The expression of SRC-1 in eutopic endometria was increased in the proliferative phase (56.5 ± 16.8) and decreased in the secretory phase (14.8 ± 6.9). In endometriosis, however, the PI for SRC-1 did not show apparent cyclic changes during the menstrual cycle. Moreover, the expression of SRC-1 in endometriotic epithelia in the proliferative phase was significantly lower than that in eutopic endometria. These findings suggested the reduced proliferative activity in endometriotic epithelia to be related to the reduced expression of SRC-1.\nSimilar content being viewed by others\nReferences\nStrauss J III, Coutifaris C (1999) The endometrium and myometrium: regulation and dysfunction. In: Yen SSC, Jaffe RB, Barbieri R (eds) Reproductive endocrinology, 4th edn. WB Saunders, Philadelphia, pp 218–256\nGiudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789–1799\nMatsuzaki S, Fukaya T, Suzuki T et al (1999) Oestrogen receptor alpha and beta mRNA expression in human endometrium throughout the menstrual cycle. Mol Hum Reprod 5:559–564\nGiudice LC (1994) Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil Steril 61:1–17\nShiozawa T, Li SF, Nakayama K et al (1996) Relationship between the expression of cyclins/cyclin-dependent kinases and sex-steroid receptors/Ki67 in normal human endometrial glands and stroma during the menstrual cycle. Mol Hum Reprod 2:745–752\nShiozawa T, Miyamoto T, Kashima H et al (2004) Estrogen-induced proliferation of normal endometrial glandular cells is initiated by transcriptional activation of cyclin D1 via binding of c-Jun to an AP-1 sequence. Oncogene 23:8603–8610\nKashima H, Horiuchi A, Uchikawa J et al (2009) Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma. Anticancer Res 29:1023–1029\nMcKenna NJ, Lanz RB, O’Malley BW (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321–344\nMcKenna NJ, O’Malley BW (2000) From ligand to response: generating diversity in nuclear receptor coregulator function. J Steroid Biochem Mol Biol 74:351–356\nShiozawa T, Shih HC, Miyamoto T et al (2003) Cyclic changes in the expression of steroid receptor coactivators and corepressors in the normal human endometrium. J Clin Endocrinol Metab 88:871–878\nUchikawa J, Shiozawa T, Shih HC et al (2003) Expression of steroid receptor coactivators and corepressors in human endometrial hyperplasia and carcinoma with relevance to steroid receptors and Ki-67 expression. Cancer 98:2207–2213\nFreedman LP (1999) Increasing the complexity of coactivation in nuclear receptor signaling. Cell 97:5–8\nHuang HJ, Norris JD, McDonnell DP (2002) Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. Mol Endocrinol 16:1778–1792\nPickartz H, Beckmann R, Fleige B et al (1990) Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria. Virchows Arch A Pathol Anat Histopathol 417:163–171\nJones RK, Bulmer JN, Searle RF (1995) Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum Reprod 10:3272–3279\nNisolle M, Casanas-Roux F, Donnez J (1997) Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 68:912–919\nMosselman S, Polman J, Dijkema R (1996) ER beta: identification and characterization of a novel human estrogen receptor. FEBS Lett 392:49–53\nFujimoto J, Hirose R, Sakaguchi H et al (1999) Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol Hum Reprod 5:742–747\nBrandenberger AW, Lebovic DI, Tee MK et al (1999) Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Mol Hum Reprod 5:651–655\nMisiti S, Schomburg L, Yen PM et al (1998) Expression and hormonal regulation of coactivator and corepressor genes. Endocrinology 139:2493–2500\nKlinge CM, Jernigan SC, Mattingly KA et al (2004) Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors. J Mol Endocrinol 33:387–410\nLeo C, Chen JD (2000) The SRC family of nuclear receptor coactivators. Gene 245:1–11\nSpencer TE, Jenster G, Burcin MM et al (1997) Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194–198\nTai H, Kubota N, Kato S (2000) Involvement of nuclear receptor coactivator SRC-1 in estrogen-dependent cell growth of MCF-7 cells. Biochem Biophys Res Commun 267:311–316\nThenot S, Charpin M, Bonnet S et al (1999) Estrogen receptor cofactors expression in breast and endometrial human cancer cells. Mol Cell Endocrinol 156:85–93\nNephew KP, Ray S, Hlaing M et al (2000) Expression of estrogen receptor coactivators in the rat uterus. Biol Reprod 63:361–367\nNoble LS, Simpson ER, Johns A et al (1996) Aromatase expression in endometriosis. J Clin Endocrinol Metab 81:174–179\nZeitoun K, Takayama K, Sasano H et al (1998) Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. J Clin Endocrinol Metab 83:4474–4480\nLeite RS, Brown AG, Strauss JF III (2004) Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: a possible mechanism contributing to changes in steroid hormone responsiveness. FASEB J 18:1418–1420\nEisermann J, Gast MJ, Pineda J et al (1988) Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 50:573–579\nShibata H, Spencer TE, Onate SA et al (1997) Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52:141–164, discussion 16\nKwok RP, Lundblad JR, Chrivia JC et al (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223–226\nZhang X, Jeyakumar M, Petukhov S et al (1998) A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Mol Endocrinol 12:513–524\nZanger K, Radovick S, Wondisford FE (2001) CREB binding protein recruitment to the transcription complex requires growth factor-dependent phosphorylation of its GF box. Mol Cell 7:551–558\nZhong H, May MJ, Jimi E et al (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9:625–636\nWieser F, Schneeberger C, Hudelist G et al (2002) Endometrial nuclear receptor co-factors SRC-1 and N-CoR are increased in human endometrium during menstruation. Mol Hum Reprod 8:644–650\nMetzger DA, Olive DL, Haney AF (1988) Limited hormonal responsiveness of ectopic endometrium: histologic correlation with intrauterine endometrium. Hum Pathol 19:1417–1424\nBulun SE, Cheng YH, Yin P et al (2006) Progesterone resistance in endometriosis: link to failure to metabolize estradiol. Mol Cell Endocrinol 248:94–103\nWagner BL, Norris JD, Knotts TA et al (1998) The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor. Mol Cell Biol 18:1369–1378\nWang D, Wang Q, Awasthi S et al (2007) Amino-terminal domain of TIF2 is involved in competing for corepressor binding to glucocorticoid and progesterone receptors. Biochemistry 46:8036–8049\nAcknowledgment\nConflict of interest statement\nWe declare that we have no conflict of interest.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nSuzuki, A., Horiuchi, A., Oka, K. et al. Immunohistochemical detection of steroid receptor cofactors in ovarian endometriosis: involvement of down-regulated SRC-1 expression in the limited growth activity of the endometriotic epithelium. Virchows Arch 456, 433–441 (2010). https://doi.org/10.1007/s00428-010-0884-x\nReceived:\nRevised:\nAccepted:\nPublished:\nIssue date:\nDOI: https://doi.org/10.1007/s00428-010-0884-x","source_license":"public-domain-us","license_restricted":false}